Aminocaproic acid is a widely used antifibrinolytic agent. Serious adverse effects associated with its use are rare, but we report on a patient with liver disease and cirrhosis who experienced a grand mal seizure during the intravenous administration of aminocaproic acid. Clinicians should be alert to the occurrence of this adverse effect in patients with no previous neurological problems.
Get full access to this article
View all access options for this article.
References
1.
AdamsHPJrNibbelinkDWTornerJCSahsAL. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. Arch Neurol1981; 38: 25–9.
2.
HoffmanEPKooAH. Cerebral thrombosis associated with Amicar therapy. Radiology1979; 131: 687–9.
3.
FefferSEParrayHRWestringDW. Seizure after infusion of aminocaproic acid. JAMA1978; 240: 2468.
QuandtCMDe Los ReyesRADiazFGAusmanJI. Pharmacologic management of subarachnoid hemorrhage. Drug Intell Clin Pharm1982; 16: 909–15.
6.
AmbrusCMAmbrusJLLassmanHBMinkIB. Studies on the mechanism of action of inhibitors of the fibrinolytic system. Ann NY Acad Sci1968; 146: 430–47.
7.
NibbelinkDWJacobsonCD. Plasminogen depletion during administration of epsilon-aminocaproic acid. Thromb Diathes Haemorrh1973; 29: 598–602.
8.
WalshPNRizzaCRMatthewsJM. Epsilon aminocaproic acid therapy for dental extraction in hemophilia and Christmas disease: A double blind controlled trial. Br J Haematol1971; 20: 468–74.
9.
WalshPNRizzaCREvansBE. The therapeutic role of epsilon amino caproic acid (EACA) for dental extractions in hemophiliacs. Ann NY Acad Sci1975; 240: 267–76.
10.
KutnerB.FourmanS.BreinK., Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema. Arch Ophthalmol1987; 105: 206–8.
11.
DiesteMCHershPSKylstraJALarrisonWIFrambachDAShingletonBJ. Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema. Am J Ophthalmol1988; 106: 383–90.
KangY.LewisJHNavalgundA., Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology1987; 66: 766–73.
14.
NibbelinkDWTornerJCHendersonWG. Intracranial aneurysms and subarachnoid haemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Stroke1975; 6: 622–9.
15.
LaneRJMRoutledgePA. Drug induced neurological disorders. Drugs1983; 26: 124–47.
16.
WarrellRPJrKempinSJ. Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med1985; 313: 309–12.
17.
VerstraeteM.Clinical application of inhibitors of fibrinolysis. Drugs1985; 29: 236–61.
